🇺🇸 FDA
Patent

US 9657292

Compositions and methods for treating or preventing lupus

granted A61KA61K31/5383A61K31/675

Quick answer

US patent 9657292 (Compositions and methods for treating or preventing lupus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/5383, A61K31/675, A61K39/395, A61K39/39533